Your browser doesn't support javascript.
loading
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors.
Ziranu, Pina; Pretta, Andrea; Pozzari, Marta; Maccioni, Antonio; Badiali, Manuela; Fanni, Daniela; Lai, Eleonora; Donisi, Clelia; Persano, Mara; Gerosa, Clara; Puzzoni, Marco; Bardanzellu, Fabio; Ambu, Rossano; Pusceddu, Valeria; Dubois, Marco; Cerrone, Giulia; Migliari, Marco; Murgia, Sara; Spanu, Dario; Pretta, Gianluca; Aimola, Valentina; Balconi, Francesca; Murru, Stefania; Faa, Gavino; Scartozzi, Mario.
Affiliation
  • Ziranu P; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Pretta A; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Pozzari M; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Maccioni A; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Badiali M; Genetic and Genomic Laboratory, Pediatric Children Hospital A. Cao ASL8, Cagliari, Italy.
  • Fanni D; Division of Pathology, Department of Medical Sciences and Public Health, University Hospital and University of Cagliari, Cagliari, Italy.
  • Lai E; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Donisi C; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Persano M; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Gerosa C; Division of Pathology, Department of Medical Sciences and Public Health, University Hospital and University of Cagliari, Cagliari, Italy.
  • Puzzoni M; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Bardanzellu F; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Ambu R; Division of Pathology, Department of Medical Sciences and Public Health, University Hospital and University of Cagliari, Cagliari, Italy.
  • Pusceddu V; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Dubois M; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Cerrone G; Division of Pathology, Department of Medical Sciences and Public Health, University Hospital and University of Cagliari, Cagliari, Italy.
  • Migliari M; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Murgia S; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Spanu D; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Pretta G; Science Department, King's School Hove, Hangleton Way, Hove, BN3 8BN, UK.
  • Aimola V; Division of Pathology, Department of Medical Sciences and Public Health, University Hospital and University of Cagliari, Cagliari, Italy.
  • Balconi F; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy.
  • Murru S; Genetic and Genomic Laboratory, Pediatric Children Hospital A. Cao ASL8, Cagliari, Italy.
  • Faa G; Division of Pathology, Department of Medical Sciences and Public Health, University Hospital and University of Cagliari, Cagliari, Italy.
  • Scartozzi M; Medical Oncology Unit, University Hospital and University of Cagliari, SS 554 km 4500 Bivio Per Sestu, 09042, Monserrato, Cagliari, Italy. marioscartozzi@gmail.com.
Sci Rep ; 13(1): 4397, 2023 03 16.
Article de En | MEDLINE | ID: mdl-36928082
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs colorectales / Tumeurs du côlon / Facteurs de transcription CDX2 / Inhibiteurs de points de contrôle immunitaires Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Sci Rep Année: 2023 Type de document: Article Pays d'affiliation: Italie Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs colorectales / Tumeurs du côlon / Facteurs de transcription CDX2 / Inhibiteurs de points de contrôle immunitaires Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Sci Rep Année: 2023 Type de document: Article Pays d'affiliation: Italie Pays de publication: Royaume-Uni